Risk of Trastuzumab-Related Cardiotoxicity in Early Breast Cancer Patients: A Prospective Observational Study

PURPOSE: In the present study, we investigated the incidence of cardiotoxicity within 5 years of trastuzumab treatment and evaluated potential risk factors in clinical practice. METHODS: The study cohort included 415 patients diagnosed with early breast cancer (EBC). Cardiotoxicity incidence was eva...

Descripción completa

Detalles Bibliográficos
Autores principales: Xue, Jian, Jiang, Zefei, Qi, Fan, Lv, Shuanghong, Zhang, Shaohua, Wang, Tao, Zhang, Xiaozhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Breast Cancer Society 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4278056/
https://www.ncbi.nlm.nih.gov/pubmed/25548585
http://dx.doi.org/10.4048/jbc.2014.17.4.363

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4278056/
https://www.ncbi.nlm.nih.gov/pubmed/25548585
http://dx.doi.org/10.4048/jbc.2014.17.4.363

Ejemplares similares